The 2025 YouGov survey data from more than 31,000 US adults show significant support for recreational cannabis legalization, medical use, and federal reclassification.
|Articles|August 30, 2019
Cannabis Science Conference West 2019 Analytical Cannabis Keynote Speaker, Day 2
Author(s)Megan L'Heureux
Dr. Ethan Russo, MD, Director of Research and Development of the International Cannabis and Cannabinoids Institute (ICCI), discusses his keynote talk “Cannabis and the Future of Psychiatry” from the 2019 Cannabis Science Conference West.
Advertisement
Dr. Ethan Russo, MD, Director of Research and Development of the International Cannabis and Cannabinoids Institute (ICCI), will give a keynote talk today in Exhibit Hall B at 9:10 a.m. The talk is titled “Cannabis and the Future of Psychiatry.” Russo recently spoke to us about his talk and what he hopes attendees will learn from it.
Can you give us a little preview of your keynote talk for the 2019 Cannabis Science Conference West?Dr. Russo: I will be speaking on “Cannabis and the Future of Psychiatry.” It is actually a huge topic for a short lecture, but we will briefly discuss the history of cannabis for mood disorders, and address impairment, depression, insomnia, post-traumatic stress, schizophrenia, anxiety, and addiction-just a taste of each. The topic is very important to me, inasmuch as this has been a long neglected area of cannabis therapeutics, particularly in light of the fact that available conventional drugs are so poorly effective in many instances. I hope that people may gain a greater understanding for the potential of cannabis-based treatment with appropriate agents in these many conditions.
What do you hope attendees will take away from your keynote?
Russo: I hope that they will gather the long historical recognition of cannabis and its role in society and an understanding of its great promise in the future.
What are you hoping to learn or take away from this year’s conference? Are there any other talks you plan to attend?
Russo: My experience last year in Portland was excellent. I will be there throughout, hoping to learn and meet with old and new friends.
Advertisement
Related to this article
Curaleaf is opening a new cannabis dispensary called Curaleaf Millcreek in Erie, Pennsylvania.
Learn how third-party audits enhance compliance in the cannabis industry, ensuring readiness for evolving regulations and fostering consumer trust.
Let’s take a look at the 2025 cannabis coverage on medical cannabis research and medicine to catch up on industry trends and innovations.
Let’s take a look at the 2025 cannabis coverage on cannabis research to catch up on industry trends and innovations.
A lack of standards for cannabis vape devices puts consumers at risk, but several organizations are committed to the research, collaboration, and solutions needed to promote safety and quality in the industry.
Cannabis genetics fundamentally dictate the plant's potential for chemical signatures, including cannabinoid and terpene profiles, and physical traits, such as yield. Cultivators use selective techniques, such as "stacking," to enhance specific compounds. Ultimately, successful cultivation involves balancing superior genetics with environmental "levers" to optimize gene expression and create targeted strains.
It’s that time of year again—the Cannabis Science and Technology (CST) top 10 articles from the previous year. CST published a wide variety of content throughout 2025. Here is just a small snippet of some of the top articles that our readers enjoyed. See if any of your favorites made the list!
Advertisement
Advertisement